Corona Remedies Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 743
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 1
  • Investments
  • 2

Corona Remedies General Information

Description

Manufacturer of pharmaceutical drugs in India. The company develops pharmaceuticals, nutraceuticals, drugs for diabetics, painkillers, gastrointestinal, antifungal, antibiotics, vitamins as well as formulations for cardio cares.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • Corona House, Block C, Mondeal Business Park, Near Gurudwara.
  • S. G. Highway, Thaltej
  • Ahmedabad, Gujarat 380059
  • India
+91 079 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Corona Remedies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Corona Remedies‘s full profile, request access.

Request a free trial

Corona Remedies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of pharmaceutical drugs in India. The company develops pharmaceuticals, nutraceuticals, drugs for diabetics
Pharmaceuticals
Ahmedabad, India
743 As of 2020
000.00
00.00 0000-00-00
0000000 0000 000.00

00000000

a. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
000000000000000
Mexico City, Mexico
000.00
0000000 0000

000 0000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
0000 000000000
Bresso, Italy
0000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Corona Remedies Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Landsteiner Scientific Private Equity-Backed Mexico City, Mexico 000.00 0000000 0000
000 000000 00000 Private Debt Financed Bresso, Italy 0000 000.00 000000000 000.00
000000 00000000000 Private Equity-Backed Pune, India 0000 000000 - 000
00000 000000000000 Formerly PE-Backed Mumbai, India 00000 00000 00000000 00000
00 00000 Venture Capital-Backed Ahmedabad, India 000 0000 0000000000 0 0000
You’re viewing 5 of 20 competitors. Get the full list »

Corona Remedies Executive Team (4)

Name Title Board Seat Contact Info
Rashesh Patel President
Ankur Mehta Director
Kirtibhai Mehta Founder & Board Member
Tejas Kothari Associate Vice President
To view Corona Remedies’s complete executive team members history, request access »

Corona Remedies Board Members (2)

Name Representing Role Since
000000000 00000 Corona Remedies Founder & Board Member 000 0000
00000 00000 Corona Remedies Board Member & Member of CSR Governance 000 0000
To view Corona Remedies’s complete board members history, request access »

Corona Remedies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Corona Remedies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Corona Remedies‘s full profile, request access.

Request a free trial

Corona Remedies Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000 (0000 02-Apr-2018 0000000000 Buildings and Property 00000 0000000
GlaxoSmithKline (Dilo-BM, Dilo-DX, Stelbid and Vitneurin) 07-Mar-2017 Buyout/LBO Buildings and Property
To view Corona Remedies’s complete investments history, request access »